An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Exscientia to Present at the BofA Securities 2022 Healthcare Conference
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Exscientia (Nasdaq: EXAI) announced that CFO Ben Taylor and CTO Garry Pairaudeau will participate in a fireside chat at the BofA Securities 2022 Healthcare Conference on Tuesday, May 10, 2022, at 5:20 p.m. P.T. A live webcast will be accessible on the Company’s website under the 'Investors & Media' section, with an archived replay available for 30 days post-event. Exscientia is an AI-driven pharmatech company focused on rapid drug discovery and development, with over 30 projects currently in progress aimed at improving patient outcomes.
Positive
None.
Negative
None.
OXFORD, England--(BUSINESS WIRE)--
Exscientia (Nasdaq: EXAI) today announced that Ben Taylor, CFO & Chief Strategy Officer and Garry Pairaudeau, Chief Technology Officer, will participate in a fireside chat at the BofA Securities 2022 Healthcare Conference on Tuesday, May 10, 2022 at 5:20 p.m. P.T.
A live webcast of the fireside chat will be available on the Company’s website, under the “Investors & Media” section at www.investors.exscientia.ai. An archived replay of the webcast will be available for approximately 30 days following the presentation.
About Exscientia Exscientia is an AI-driven pharmatech company committed to discovering, designing and developing the best possible drugs in the fastest and most effective manner. Exscientia developed the first-ever functional precision oncology platform to successfully guide treatment selection and improve patient outcomes in a prospective interventional clinical study, as well as to progress AI-designed small molecules into the clinical setting. Our pipeline demonstrates our ability to rapidly translate scientific concepts into precision-designed therapeutic candidates, with more than 30 projects underway. By designing better drugs, faster, we believe the best ideas of science can rapidly become the best medicines for patients.
Exscientia is headquartered in Oxford (England, U.K.), with offices in Vienna (Austria), Dundee (Scotland, U.K.), Boston (Mass., U.S.), Miami (Fla., U.S.), Cambridge (England, U.K.), and Osaka (Japan).
What date will Exscientia participate in the BofA Securities 2022 Healthcare Conference?
Exscientia will participate in the BofA Securities 2022 Healthcare Conference on May 10, 2022.
What time is Exscientia's fireside chat at the BofA Securities Conference?
The fireside chat will take place at 5:20 p.m. P.T.
Where can I watch the Exscientia fireside chat live?
The fireside chat can be viewed live on Exscientia’s website in the 'Investors & Media' section.
How long will the Exscientia fireside chat replay be available?
The archived replay of the fireside chat will be available for approximately 30 days after the presentation.
What is Exscientia's focus in drug development?
Exscientia is focused on AI-driven drug discovery and development, with a commitment to improving patient outcomes through precision-designed therapeutic candidates.
